Greg Bosch

Greg Bosch is currently the Chairman & CEO of Panavance Therapeutics Inc. Greg also serves as a Strategic Advisor at Autem Therapeutics and a Board Member at Kibow Biotech. Previously, Greg held the position of CEO at Geistlich Pharma North America and President & CEO at PuriCore. With a background in public policy and finance, Greg has extensive experience in the pharmaceutical and healthcare industries.